Summary of Purpose
To prospectively evaluate the use of intravenous rt-PA in Canada. Thrombolytic therapy for acute stroke in Canada was conditionally approved in 1999; this study was a mandated by the federal government as a condition for full approval.Read More →
The following dates are available for this trial. Trial information last updated on 28 July 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Canadian Stroke Consortium, Canadian Stroke Network, and Hoffman-La Roche Canada Ltd.
Open label, multi-center post-marketing study.
CASES Study Group Calgary, AB, CanadaMichael.firstname.lastname@example.org